Commentary: Wagering on Trifecta

[摘要] Anecdotal reports of early failure of the Trifecta bioprosthetic valve despite promising early improved hemodynamics have spurred efforts to quantify these observations. Squiers and colleagues1 demonstrate in their analysis of the literature that the Trifecta bioprosthetic valve is associated with greater rates of structural valve degeneration (SVD) or reintervention for SVD than the Magna Ease, as well as greater rates of all-cause reintervention compared with the Magna Ease and PERIMOUNT.

[学科分类] 心脏病和心血管学